While there was no specific inflammation pathway that showed differential methylation, an inflammatory-related gene such as IL2 receptor alpha (IL2RA) included in the pathways in cancer was affected by the differential methylation between non-responders and responders. The gene discussed is IL2RA; the disease is cancer.